Transplant Medicine
Researchers report details of new studies and findings in the area of transplant medicine
Published in Blood Weekly, November 24th, 2005
Study 1: Valganciclovir is suitable for use in the management of cytomegalovirus (CMV) disease in patients undergoing solid organ transplantation.
In a recent study from Canada, "virologic and clinical outcomes" in valganciclovir-treated transplant recipients "were compared with those in matched historical control individuals."
"Thirty-two patients (23 with symptomatic disease) received valganciclovir, and 32 patients received intravenous (i.v.) ganciclovir," noted A. Humar and colleagues working at Toronto General Hospital. "The rate of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-11-24)
More Articles from Blood Weekly
- Blood Safety
Study shows ligand technology effective in removing blood-borne TSE infectivity - Diagnostics
Blood bank safety advanced with U.S. launch of hepatitis test - Stem Cell Transplantation
Increased TNF levels associated with increased risk of CMV infection after AHSCT - Stem Cell Transplantation
Protein C levels during HSCT conditioning do not predict veno-occlusive disease - Adverse Drug Reaction
Patients develop acute liver failure after receiving amoxicillin/clavulanate - Allergy & Immunology
Donor HLA alleles may control hepatitis C virus spread to liver grafts - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
